Kyorin Pharmaceutical Co. Ltd. struck two licensing deals recently, including one with Hyfe Inc. Feb. 25 to develop the world ...
Claims are now open for a $4.5 million settlement resolving a class-action lawsuit that alleged Robitussin was falsely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback